To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06126588
Title Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial (ELUMEN)
Acronym ELUMEN
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Central Hospital, Nancy, France
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHRU of Nancy NOT_YET_RECRUITING Vandœuvre-lès-Nancy Grand Est 54511 France Details
Nancy Hospital RECRUITING Vandœuvre-lès-Nancy 54511 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field